SNDA Stock Analysis: Sonida Senior Living | NYSE
Medical Care Facilities | NYSE, USA | Market Cap: 1.998m USD | 12M Return: 57.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.6M
Qual. Beats: -3
Rev. Trend: 99.5%
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Sonida Senior Living, Inc. (NYSE: SNDA) is a Dallas-based operator of senior housing communities in the United States, founded in 1990 and previously known as Capital Senior Living Corporation until its November 2021 rebranding. The company generates revenue from three primary service lines: independent living, which bundles housing with meals, housekeeping, transportation, recreational activities, and 24-hour staffing; assisted living, which adds personal care support such as help with bathing, dressing, grooming, and medication management; and memory care, which serves residents with dementia and related conditions. Sonida also supplements its offering with respite care, short-stay programs, and third-party home care services covering physician, dental, podiatry, and therapy visits.
The senior housing industry is generally classified within the healthcare sector, with operators typically earning revenue through a combination of monthly resident fees, entrance or community fees, and ancillary service charges. Senior living providers like Sonida operate within a continuum-of-care model, meaning residents can transition between independent living, assisted living, and memory care as their needs change, which is intended to support longer tenancies and recurring monthly revenue streams. Demand for these services is driven primarily by demographic aging, particularly the growth of the population aged 75 and older.
- Senior housing occupancy recovery drives same-store revenue growth
- Labor cost inflation pressures assisted living operating margins
- Rising interest expense from refinanced debt weighs on earnings
| Net Income: -99.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 0.83 > 1.0 |
| NWC/Revenue: -45.40% < 20% (prev -5.28%; Δ -40.12% < -1%) |
| CFO/TA -0.01 > 3% & CFO -15.3m > Net Income -99.5m |
| Current Ratio: 0.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.1m) vs 12m ago 0.33% < -2% |
| Gross Margin: -29.88% > 18% (prev 89.93%; Δ -119.8% > 0.5%) |
| Asset Turnover: 23.86% > 50% (prev 39.88%; Δ -16.02% > 0%) |
| Interest Coverage Ratio: -1.37 > 6 (EBIT TTM -58.0m / Interest Expense TTM 42.4m) |
| A: -0.07 (Total Current Assets 146.7m - Total Current Liabilities 333.7m) / Total Assets 2.63b |
| B: -0.20 (Retained Earnings -532.2m / Total Assets 2.63b) |
| C: -0.03 (EBIT TTM -58.0m / Avg Total Assets 1.73b) |
| D: 0.51 (Book Value of Equity 884.9m / Total Liabilities 1.74b) |
| Altman-Z'' = -0.82 = CCC |
| DSRI: 1.26 (Receivables 26.0m/16.5m, Revenue 411.9m/328.8m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 2.48 (AQ_t 0.11 / AQ_t-1 0.04) |
| SGI: 1.25 (Revenue 411.9m / 328.8m) |
| TATA: -0.03 (NI -99.5m - CFO -15.3m) / TA 2.63b) |
| Beneish M = -1.76 (Cap -4..+1) = CCC |
As of July 11, 2026, the stock is trading at USD 40.47 with a total of 584,362 shares traded. Over the past week, the price has changed by -4.12%, over one month by +12.89%, over three months by +24.22% and over the past year by +57.10%.
Current recommended Stop Loss: 37.80 (which is 6.6% or 1.7 ATR below the current price).
Sonida Senior Living has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold SNDA.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 41.3 | 1.9% |
P/E Forward = 20.4918
P/S = 5.4404
P/B = 2.2585
P/EG = 2.0444
Revenue TTM = 411.9m USD
EBIT TTM = -58.0m USD
EBITDA TTM = 5.00m USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 218.7m USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter) + Leases 566k
Net Debt = 1.54b USD (calculated: Debt 1.62b - CCE 84.3m)
Enterprise Value = 3.54b USD (2.00b + Debt 1.62b - CCE 84.3m)
Interest Coverage Ratio = -1.37 (Ebit TTM -58.0m / Interest Expense TTM 42.4m)
EV/FCF = -75.18x (Enterprise Value 3.54b / FCF TTM -47.1m)
FCF Yield = -1.33% (FCF TTM -47.1m / Enterprise Value 3.54b)
FCF Margin = -11.42% (FCF TTM -47.1m / Revenue TTM 411.9m)
Net Margin = -24.15% (Net Income TTM -99.5m / Revenue TTM 411.9m)
Gross Margin = -29.88% ((Revenue TTM 411.9m - Cost of Revenue TTM 534.9m) / Revenue TTM)
Gross Margin QoQ = -10.09% (prev -156.5%)
Tobins Q-Ratio = 1.35 (Enterprise Value 3.54b / Total Assets 2.63b)
Interest Expense / Debt = 2.61% (Interest Expense 42.4m / Debt 1.62b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -45.9m (EBIT -58.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.44 (Total Current Assets 146.7m / Total Current Liabilities 333.7m)
Debt / Equity = 1.83 (Debt 1.62b / totalStockholderEquity, last quarter 884.9m)
Debt / EBITDA = 307.5 (Net Debt 1.54b / EBITDA 5.00m)
Debt / FCF = -32.70 (negative FCF - burning cash) (Net Debt 1.54b / FCF TTM -47.1m)
Total Stockholder Equity = 281.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -5.76% (Net Income -99.5m / Total Assets 2.63b)
RoE = -35.37% (Net Income TTM -99.5m / Total Stockholder Equity 281.3m)
RoCE = -3.44% (EBIT -58.0m / Capital Employed (Equity 281.3m + L.T.Debt 1.40b))
RoIC = -1.84% (negative operating profit) (NOPAT -45.9m / Invested Capital 2.49b)
WACC = 5.41% (E(2.00b)/V(3.62b) * Re(8.13%) + D(1.62b)/V(3.62b) * Rd(2.61%) * (1-Tc(0.21)))
Discount Rate = 8.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 94.39 | Cagr: 49.46%
[DCF] Fair Price = unknown (Cash Flow -47.1m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -2.55 | # QB: -3
Revenue Correlation: 99.53 | Revenue CAGR: 26.02% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.70 | Chg30d=+12.50% | Revisions=+0% | Analysts=1
EPS next Quarter (2026-09-30): EPS=-0.63 | Chg30d=-7.69% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=-2.97 | Chg30d=+4.96% | Revisions=-25% | GrowthEPS=+29.6% | GrowthRev=+91.3%
EPS next Year (2027-12-31): EPS=-0.94 | Chg30d=-108.89% | Revisions=-25% | GrowthEPS=+68.3% | GrowthRev=+15.9%
[Analyst] Revisions Ratio: -40% (up=0, down=2)